[1]
Shrestha, G.S., Bista, B., Dhungana, A., Poudel, N., Bhattarai, S., Shrestha, M., Bhandari, S. and Vaidya, B. 2021. Tofacitinib as an Adjunct Immunomodulator for Treatment of a Patient with Severe COVID-19: A Case Report. Journal of Nepal Medical Association. 59, 238 (Jul. 2021), 593–596. DOI:https://doi.org/10.31729/jnma.6680.